Colombia’s National Institute for Food and Drug Surveillance (Invima) and the United States Pharmacopeia (USP) celebrate the signing of a Memorandum of Understanding, which aims to formalize and strengthen ties and cooperation to promote the quality of medicines that the Colombians have access to.
As reported by Invima, through this agreement, the ties of cooperation between the two entities are strengthened, allowing the generation of spaces for dialogue and exchange of experiences based on good regulatory practices and The capabilities of both the institutions to guarantee quality medicines are made safe and effective. in our area.
The unit’s general director, Julio Cesare Aldana, confirmed that INVIMA is one of 70 government entities and voting associations within the United States Pharmacopoeia Convention.Which contributes to working hand in hand with the North American organization, to instill confidence in medicine in the world.
“This has allowed us to operate smoothly since 2014, which has been formalized with the signing of the MoU today, and which will allow us to strengthen our capabilities to meet the new challenges,” Aldana said. assured, remembering that this opens up spaces to move forward in better regulatory practices that certainly result in better quality, safer and more effective drugs.
The official stressed that one voice and one vote reaffirm Colombia’s commitment that the decisions made are supported by academic and scientific facts that guarantee the promotion and protection of public health in this country.
Among the major agreements signed in this MoU withA United States Pharmacopeia (USP), a non-profit organization focused on building confidence in the supply of safe and quality medicines, works to strengthen global supply chains.Through scientific rigor and the public quality standards established by it, the following are distinguished:
To provide technical and scientific support and assistance to improve access to medicines with quality assurance.
– Organize scientific events, seminars, conferences, meetings, workshops and symposia. To promote internship programmes, technical visits and training including on-site modules.
– Accept the participation of representatives of the parties in scientific and expert committees or working groups as observers or ad-hoc advisors.
– Share experience and information on the development of analytical methods. Jointly develop projects for the establishment, development and/or revision of monograph and analytical methods.
It is anticipated that due to the crisis in the supply chain, which has affected the availability of medicines across the world, especially from the East, the region’s exports will increase. According to a study by ProColombia, the fact that the country complies with local regulations for the production of pharmaceutical products facilitates health registration approval processes in other markets.
Given this situation, the pharmaceutical industry in Colombia will continue to see growth opportunities this year towards sectors that have the potential to build them.
On the other hand, thanks to the new drug price control regulation that came into force at the end of 2021, a total of 2,489 drugs have a maximum selling price for this 2022. The new regulation has set a maximum price for marketing, taking into account the average adjustment factors observed in the countries of our reference, between the point of manufacture and the point of wholesale, which corresponds to 6.1%.